2026-03-04T15:44:00-06:00 2025-06-30 464553740 MANN & ASSOCIATES APC 2535 TRUXTUN ROAD STE 207 SAN DIEGO CA 92106 990EZ 2024-07-01 208965505 LA JOLLA INFECTIOUS DISEASE INSTITUTE LAJO 8584814198 3525 DEL MAR HEIGHTS ROAD 453 SAN DIEGO CA 92130 HENRI VAN DER HEYDE CFO 8584814198 2026-03-03 1 1 JEANNE M MANN CPA P00229468 6192225900 2024 2025-03-06 01:10:19Z X X WWW.LJIDI.ORG X X 10718 X 1718 9000 0 9000 10718 16 16 10702 -785727 0 -775025 X 13385 0 5668 0 19053 0 804780 775025 -785727 -775025 X THE SPECIFIC PURPOSE OF THIS CORPORATION IS FOR THE ADVANCEMENT OF SCIENCE AND FOR RESEARCH PURPOSES AS DEFINED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, INCLUDING THE IMPROVED TREATMENT, RESEARCH DESIGN AND METHODS, AND KNOWLEDGE RELATED TO THE ALLERGIC RESPONSE, INFECTIOUS DISEASE, AND IMMUNOLOGIC PATHWAYS. WE PROVIDE EDUCATIONAL ACTIVITIES FOR SCHOOL CHILDREN, UNDERGRADUATE, GRADUATE, AND POST-DOCTORAL STUDENTS. 1 JOHNS HOPKINS: STUDIES TO EXAMINE FACTORS THAT ARE SECRETED INTO THE MOUSE BRAIN DURING EXPERIMENTAL CEREBRAL MALARIA AND THAT CONTRIBUTE TO PATHOGENESIS. 2 WUN-LING CHANG MD INC PROVIDES FUNDING FOR PILOT STUDIES, DEVELOPMENT OF NANOPARTICLES CONJUGATED WITH DRUGS FOR IMPROVED KILLING OF PLASMODIUM AS WELL AS POTENTIAL ADJUNCTIVE EFFECTS AGAINST EXPERIMENTAL CEREBRAL MALARIA AND DEVELOPMENT OF NEW TREATMENTS AGAINST STREPTOCOCCUS PNEUMONIAE. 0 0 0 WUN-LING CHANG MD PRESIDENT, CEO 2.00 0 0 0 HENRI VAN DER HEYDE PHD CFO 15.00 0 0 0 GEORGES E GRAU MD PHD DIRECTOR 1.00 0 0 0 KENNY CHU DIRECTOR 1.00 0 0 0 AUTEL PATEL DIRECTOR 1.00 0 0 0 X 0 0 0 0 1 0 1 775025 0 0 0 0 0 0 0 CA HENRI VAN DER HEYDE 3525 DEL MAR HEIGHTS ROAD SUITE 453 SAN DIEGO CA 92130 8584814198 0 0 0 0 0 0 0 0 0 0 NONE NONE 1 X 307799 219974 480865 25829 1718 1036185 307799 219974 480865 25829 1718 1036185 7507 10730 4513 22750 0 7507 10730 4513 22750 1013435 9000 9000 9000 9000 307799 219974 480865 25829 10718 1045185 0.96960 0.00010 0.00860 0.00010 X WUN-LING CHANG MD CEO LINE OF CREDIT TO FUND THE ORGANIZATION'S FINANCIAL NEEDS. X 1000000 775025 0 1 1 775025 ALL EQUIPMENT WAS SOLD FOR $9,000 AND USED TO PAY DEBTS. 2024-07-01 9000 VALUE OF SIMILAR EQUIPMENT . 0 0 0 0 FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES DESCRIPTION: MISCELLANOUS. AMOUNT: 16. FORM 990-EZ, PART II, LINE 24 - OTHER ASSETS DESCRIPTION: OTHER ASSETS. BEG. OF YEAR AMOUNT: 4,321. END OF YEAR AMOUNT: 0. DESCRIPTION: SECURITY DEPOSIT. BEG. OF YEAR AMOUNT: 1,347. END OF YEAR AMOUNT: 0. FORM 990-EZ, PART II, LINE 26 - OTHER LIABILITIES DESCRIPTION: LOANS FROM OFFICER. BEG. OF YEAR AMOUNT: 804,780. END OF YEAR AMOUNT: 775,025. THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.